<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2025.1637666</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptome-guided engineering of a native niacin transporter in <italic>Lactiplantibacillus plantarum</italic> unveils metabolic rewiring for NMN biosynthesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name><surname>Kong</surname> <given-names>Linghui</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/596596/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Li</surname> <given-names>Xinyu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2906668/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>He</surname> <given-names>Qing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yao</surname> <given-names>Qingshou</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2908079/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ai</surname> <given-names>Lianzhong</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Qin</surname> <given-names>Jiayang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/765606/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>School of Pharmacy, Binzhou Medical University</institution>, <addr-line>Yantai, Shandong</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>School of Agriculture and Biology, Shanghai Jiao Tong University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0002">
<p>Edited by: Bo Yang, Jiangnan University, China</p></fn>
<fn fn-type="edited-by" id="fn0003">
<p>Reviewed by: Zhe Zhang, Ocean University of China, China</p>
<p>Jinsong Gu, University of Jinan, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Linghui Kong, <email>linghuikong_chn@163.com</email></corresp>
<corresp id="c002">Jiayang Qin, <email>qinjy@bzmc.edu.cn</email></corresp>
<fn fn-type="equal" id="fn0001"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>07</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1637666</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Kong, Li, He, Yao, Ai and Qin.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Kong, Li, He, Yao, Ai and Qin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>&#x03B2;-nicotinamide mononucleotide (NMN), a precursor of NAD<sup>+</sup>, holds promise as a functional food ingredient for mitigating age-related decline. This study enhanced NMN biosynthesis in probiotic <italic>Lactiplantibacillus plantarum</italic>.</p>
</sec>
<sec>
<title>Methods</title>
<p>A putative niacin transporter, <italic>lp2514</italic>, was identified via molecular docking and validated by CRISPR/Cas9. A dual-copy expression strategy was also employed to increase NMN production. In parallel, RNA-seq was used to analyze genome-wide transcriptional changes associated with enhanced NMN biosynthesis.</p>
</sec>
<sec>
<title>Results</title>
<p>Overexpression of <italic>lp2514</italic> increased NMN production by 62.3%, and a dual-copy strategy raised NMN titers to 203&#x202F;&#x03BC;mol&#x202F;L<sup>&#x2212;1</sup>-269% increase compared to empty-vector control without NAM and the highest yield reported in lactic acid bacteria. Transcriptomic analysis revealed 598 differentially expressed genes, including upregulated ribosomal proteins (<italic>rpsJ, rplE</italic>) and NAD<sup>+</sup> salvage enzymes (<italic>aspA</italic>), indicating enhanced translation and precursor flux. Deleting <italic>cinA</italic>, encoding a metabolic constraint, further boosted NMN levels, confirming transcriptomic predictions.</p>
</sec>
<sec>
<title>Discussion</title>
<p>This combined transporter engineering and transcriptome-guided strategy establishes a food-grade <italic>L. plantarum</italic> platform for efficient NMN production in functional fermented foods.</p>
</sec>
</abstract>
<kwd-group>
<kwd>nicotinamide mononucleotide</kwd>
<kwd>niacin transporter</kwd>
<kwd>multicopy engineering</kwd>
<kwd>transcriptomic analysis</kwd>
<kwd>CRISPR/Cas9</kwd>
<kwd><italic>Lactiplantibacillus plantarum</italic></kwd>
</kwd-group>
<counts>
<fig-count count="10"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="31"/>
<page-count count="15"/>
<word-count count="7370"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Food Microbiology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>&#x03B2;-nicotinamide mononucleotide (NMN), one of an important precursor of nicotinamide adenine dinucleotide (NAD<sup>+</sup>), is naturally present as a bioactive nucleotide (<xref ref-type="bibr" rid="ref3">Cheng et al., 2024</xref>; <xref ref-type="bibr" rid="ref5">He et al., 2022</xref>). Given the decline in NAD<sup>+</sup> levels with increasing age, NAD<sup>+</sup> supplementation could offer potential benefits in preventing age-related diseases, including metabolic disorders and cardiovascular dysfunctions (<xref ref-type="bibr" rid="ref20">Nadeeshani et al., 2022</xref>; <xref ref-type="bibr" rid="ref22">Poddar et al., 2019</xref>, <xref ref-type="bibr" rid="ref9001">Kuerec et al., 2024</xref>; <xref ref-type="bibr" rid="ref28">Yang et al., 2021</xref>; <xref ref-type="bibr" rid="ref29">Yoshino et al., 2018</xref>). Owing to its beneficial effects, NMN has gained attention as a functional food ingredient for supporting healthy aging and disease prevention (<xref ref-type="bibr" rid="ref16">Luo et al., 2023</xref>). While chemical synthesis and enzymatic methods for NMN production exist, microbial fermentation offers a sustainable and cost-effective alternative (<xref ref-type="bibr" rid="ref2">Bi et al., 2023</xref>; <xref ref-type="bibr" rid="ref26">Wang et al., 2023</xref>).</p>
<p><italic>Lactiplantibacillus plantarum</italic>, a generally recognized as safe (GRAS) lactic acid bacterium (LAB), has emerged as an attractive microbial chassis for functional compound biosynthesis, due to its probiotic attributes, food compatibility, and robust metabolic versatility (<xref ref-type="bibr" rid="ref15">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="ref21">Oleksy and Klewicka, 2016</xref>; <xref ref-type="bibr" rid="ref11">Kong et al., 2024</xref>). Recent studies in <italic>Escherichia coli</italic> have demonstrated the feasibility of NMN production from inexpensive substrates such as nicotinamide (NAM), primarily through enhancement of NAM uptake and its conversion via the NAD<sup>+</sup> salvage pathway (<xref ref-type="bibr" rid="ref8">Huang et al., 2023</xref>; <xref ref-type="bibr" rid="ref14">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="ref18">Maharjan et al., 2021</xref>; <xref ref-type="bibr" rid="ref23">Shoji et al., 2021</xref>) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). <xref ref-type="bibr" rid="ref19">Marinescu et al. (2018)</xref> proposed a strategy for cost-effective NMN production in the presence of NAM, resulting in the production of NMN at 15.42&#x202F;mg&#x202F;L<sup>&#x2212;1</sup>. The yield of NMN was 16.2&#x202F;g&#x202F;L<sup>&#x2212;1</sup> with a molar conversion rate of 97.0% from NAM in <italic>E. coli</italic> (<xref ref-type="bibr" rid="ref6">Huang et al., 2022</xref>). These studies suggest that the biosynthesis of NMN by inexpensive NAM uptake has the advantage of reducing production costs. NAM often remains at low concentrations within the host, and niacin transporters (NiaPs) restrict the entry of NAM into the host cell (<xref ref-type="bibr" rid="ref1">Bao et al., 2025</xref>). However, <italic>E. coli</italic> is not suitable for direct application in food systems, and efficient NAM transporters for NMN biosynthesis have not been characterized in LAB.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Schematic diagram of NMN biosynthesis using NAM and glucose. <italic>Nampt</italic>, NAM phosphoribosyltransferase; <italic>prs</italic>, ribose-phosphate diphosphokinase; <italic>zwf</italic>, glucose 6-phosphate dehydrogenase; <italic>gnd</italic>, 6-phosphogluconate dehydrogenase; <italic>rpiA</italic>, ribose 5-phosphate isomerase A; <italic>rpiB</italic>, ribose 5-phosphate isomerase B; NiaP, niacin transporter.</p>
</caption>
<graphic xlink:href="fmicb-16-1637666-g001.tif">
<alt-text content-type="machine-generated">Metabolic pathway diagram showing the conversion of glucose to nicotinamide mononucleotide (NMN) and nicotinamide (NAM) via the pentose phosphate (PP) pathway. Key intermediates include glucose 6-phosphate, 6-phosphate-gluconate, and D-ribulose 5-phosphate. Enzymes zwf, gnd, rpiA, rpiB, and prs are involved, utilizing NADP+, NADPH, ATP, and AMP. Phosphoribosyl pyrophosphate is a key intermediate, with PRPP and NAM converting further. Transport proteins PnuC and Niap coordinate NMN and NAM movement across the membrane.</alt-text>
</graphic>
</fig>
<p>In this study, a native NiaP gene, <italic>lp2514</italic>, was identified and engineered in <italic>L. plantarum</italic> WCFS1-a well-characterized strain, with CRISPR-based tools to investigate its capacity for food-safe NMN production (<xref ref-type="bibr" rid="ref6">Huang et al., 2022</xref>; <xref ref-type="bibr" rid="ref10">Kleerebezem et al., 2003</xref>). We hypothesize that <italic>lp2514</italic> overexpression, combined with multicopy chromosomal integration, enhances NAM uptake and metabolic flux toward NMN, while transcriptomic profiling elucidates the systemic adaptations underlying yield optimization. This integrated approach establishes a food-grade microbial platform for functional NMN-enriched fermentation and provides new insights into metabolic control points for probiotic strain optimization.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec3">
<label>2.1</label>
<title>Bacterial strains, plasmids, and culture conditions</title>
<p>All strains and plasmids used in this study are listed in <xref ref-type="table" rid="tab1">Table 1</xref>. <italic>E. coli</italic> DH5&#x03B1; strains were employed as the cloning hosts for plasmid construction. <italic>E. coli</italic> DH5&#x03B1; containing genome editing plasmid was cultivated in Luria-Bertani medium supplemented with 50&#x202F;&#x03BC;g&#x202F;mL<sup>&#x2212;1</sup> kanamycin (Kan). <italic>L. plantarum</italic> WCFS1 was routinely cultured on MRS media without agitation. Then, 10&#x202F;&#x03BC;g&#x202F;mL<sup>&#x2212;1</sup> erythromycin (Em) and 10&#x202F;&#x03BC;g&#x202F;mL<sup>&#x2212;1</sup> chloramphenicol were added as needed. An appropriate quantity of NAM was introduced during the culture of <italic>L. plantarum</italic> WCFS1 to increase the biosynthesis of NMN.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Strains and plasmids used in this study.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Strain/plasmid</th>
<th align="left" valign="top">Characteristics</th>
<th align="left" valign="top">Source</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle"><italic>Escherichia coli</italic> DH5&#x03B1;</td>
<td align="left" valign="middle">Host for cloning</td>
<td align="left" valign="middle">Our lab</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>Lactococcus lactis</italic> NZ9000</td>
<td align="left" valign="middle">Wild type; Cloning host for LLNZ00315 gene</td>
<td align="left" valign="middle">Our lab</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>Streptococcus thermophilus</italic> S-3</td>
<td align="left" valign="middle">Wild type; Cloning host for orf1015 gene</td>
<td align="left" valign="middle">Our lab</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>Lactobacillus plantarum</italic> WCFS1</td>
<td align="left" valign="middle">Wild type;</td>
<td align="left" valign="middle">Our lab</td>
</tr>
<tr>
<td align="left" valign="middle">WCFS1&#x0394;<italic>lp2514</italic></td>
<td align="left" valign="middle"><italic>lp2514</italic> knockout mutant of WCFS1</td>
<td align="left" valign="middle">This study</td>
</tr>
<tr>
<td align="left" valign="middle">WCFS1&#x0394;<italic>cinA</italic></td>
<td align="left" valign="middle"><italic>cinA</italic> knockout mutant of WCFS1</td>
<td align="left" valign="middle">This study</td>
</tr>
<tr>
<td align="left" valign="middle">pKLH32</td>
<td align="left" valign="middle">Shuttle vector for <italic>E. coli</italic> and lactic acid bacteria with the constitutive P<sub>23</sub> promoter; kanamycin resistance (Kan<sup>r</sup>)</td>
<td align="left" valign="middle">Our lab</td>
</tr>
<tr>
<td align="left" valign="middle">pKLH32-LLNZ00315</td>
<td align="left" valign="middle">pKLH32 derived, carrying <italic>LLNZ00315</italic> gene from <italic>L. lactis</italic> at <italic>Bam</italic> HI and <italic>Eco</italic> RI sites; Kan<sup>r</sup></td>
<td align="left" valign="middle">This study</td>
</tr>
<tr>
<td align="left" valign="middle">pKLH32-orf1015</td>
<td align="left" valign="middle">pKLH32 derived, carrying <italic>orf1015</italic> gene from <italic>S. thermophilus</italic> at <italic>Bam</italic> HI and <italic>Eco</italic> RI sites; Kan<sup>r</sup></td>
<td align="left" valign="middle">This study</td>
</tr>
<tr>
<td align="left" valign="middle">pLXY04</td>
<td align="left" valign="middle">pKLH32 derived, carrying <italic>lp2514</italic> gene at <italic>Bam</italic> HI and <italic>Eco</italic> RI sites; Kan<sup>r</sup></td>
<td align="left" valign="middle">This study</td>
</tr>
<tr>
<td align="left" valign="middle">pLXY09</td>
<td align="left" valign="top">Derived from pLXY04, for overexpression of <italic>lp2514</italic> gene (two copy gene of lp2514)</td>
<td align="left" valign="middle">This study</td>
</tr>
<tr>
<td align="left" valign="middle">pLXY10</td>
<td align="left" valign="top">Derived from pLXY09, for overexpression of <italic>lp2514</italic> gene (three copy gene of lp2514).</td>
<td align="left" valign="middle">This study</td>
</tr>
<tr>
<td align="left" valign="middle">pLCP</td>
<td align="left" valign="middle">CRISPR/Cas9 system for <italic>L. plantarum</italic> erythromycin (Em<sup>r</sup>)</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref7">Huang et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">pLH01</td>
<td align="left" valign="middle"><italic>L. plantarum</italic> recombination helper plasmid, chloramphenicol (Cm<sup>r</sup>)</td>
<td align="left" valign="middle">
<xref ref-type="bibr" rid="ref7">Huang et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left" valign="middle">pHH13</td>
<td align="left" valign="middle">pLCP derived, carrying arms of <italic>cinA</italic> from WCFS1 and sgRNA at <italic>Apa</italic> I and <italic>Xba</italic> I sites; Kan<sup>r</sup></td>
<td align="left" valign="middle">This study</td>
</tr>
<tr>
<td align="left" valign="middle">pLXY07</td>
<td align="left" valign="middle">pLCP derived, carrying arms of <italic>lp2514</italic> from WCFS1 and sgRNA at <italic>Apa</italic> I and <italic>Xba</italic> I sites; Kan<sup>r</sup></td>
<td align="left" valign="middle">This study</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Plasmid constructions</title>
<p>All primers used in this study are listed in <xref ref-type="table" rid="tab2">Table 2</xref>, and the successful plasmids were validated by DNA sequencing. The pair of primers was used to amplify <italic>LLNZ00315</italic>, <italic>orf1015</italic> and <italic>lp2514</italic> genes from <italic>L. lactis</italic> NZ9000, <italic>Streptococcus thermophilus</italic> S-3 and WCFS1, respectively, and inserted into pKLH32 (digested with <italic>Bam</italic> HI/<italic>Eco</italic> RI) to create plasmids for NMN production. To further enhance <italic>lp2514</italic> expression, multi-copy expression cassettes were constructed. A second copy of <italic>lp2514</italic> was amplified and inserted into a separate expression region of the pKLH32 backbone, generating pLXY09 (dual-copy <italic>lp2514</italic>). To explore the effect of additional copies, pLXY10 was constructed by inserting three tandem copies of <italic>lp2514</italic>.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Primers used in this study.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Primers</th>
<th align="left" valign="top">Sequence (5&#x2019;-3&#x2019;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Lp2514-F</td>
<td align="left" valign="top">AATGACAATGATGTTGGATCCATGGTCGAAAGTAAAAGAAATAGTG</td>
</tr>
<tr>
<td align="left" valign="top">Lp2514-R</td>
<td align="left" valign="top">AGATCTCGAGCTCTAGAATTCTTAATCATCCGTCTCTTGATTCG</td>
</tr>
<tr>
<td align="left" valign="top">gRNA-lp2514-F</td>
<td align="left" valign="top">CATACTATGATATATTCTAGACCGCGCAACACCAAAACGCTGTTTTAGAGCTAGAAATA</td>
</tr>
<tr>
<td align="left" valign="top">gRNA-new-R</td>
<td align="left" valign="top">AAAAAAAGCACCGACTCGGT</td>
</tr>
<tr>
<td align="left" valign="top">lp2514-up-F</td>
<td align="left" valign="top">ACCGAGTCGGTGCTTTTTTTTCACGCCTGTACACCACGAAG</td>
</tr>
<tr>
<td align="left" valign="top">lp2514-up-R</td>
<td align="left" valign="top">GTATCGGTGGCAGATATAAATTAAATCG</td>
</tr>
<tr>
<td align="left" valign="top">lp2514-down-F</td>
<td align="left" valign="top">TTTATATCTGCCACCGATACTCCAATACTCCCCCAAATTTCCTA</td>
</tr>
<tr>
<td align="left" valign="top">lp2514-down-R</td>
<td align="left" valign="top">TCTTTTTCTAAACTAGGGCCCATCAAAGCGGATGTCTGGGAA</td>
</tr>
<tr>
<td align="left" valign="top">lp2514-confirm-F</td>
<td align="left" valign="top">GGCACAATGATGACACATGCC</td>
</tr>
<tr>
<td align="left" valign="top">lp2514-confirm-R</td>
<td align="left" valign="top">CAATGCGCGTTACCATTAATCGC</td>
</tr>
<tr>
<td align="left" valign="top">lp2514-inter-F</td>
<td align="left" valign="top">TGCCGGAATGCCAAATCCAA</td>
</tr>
<tr>
<td align="left" valign="top">lp2514-inter-R</td>
<td align="left" valign="top">GTGGTCCGCTAAATATCGACGAG</td>
</tr>
<tr>
<td align="left" valign="top">gRNA-CinA-F</td>
<td align="left" valign="top">catactatgatatattctagaaaccccggacacactgccgagttttagagctagaaata</td>
</tr>
<tr>
<td align="left" valign="middle">CinA-up-F</td>
<td align="left" valign="top">accgagtcggtgctttttttCATTTTCACGGCCTTGACCA</td>
</tr>
<tr>
<td align="left" valign="middle">CinA-up-R</td>
<td align="left" valign="top">ACGAACTTTTGTTCGCTTTTTGCTT</td>
</tr>
<tr>
<td align="left" valign="middle">CinA-down-F</td>
<td align="left" valign="middle">ctttaactccaaacttctaaGCCATATATGCCTCCCCGTA</td>
</tr>
<tr>
<td align="left" valign="middle">CinA-down-R</td>
<td align="left" valign="middle">tctttttctaaactagggcccACGACGGTTAAGTTCCAGTTTG</td>
</tr>
<tr>
<td align="left" valign="middle">pLL-seq-F</td>
<td align="left" valign="middle">CACTGATTGGTGTATCATTTCGT</td>
</tr>
<tr>
<td align="left" valign="middle">pLL-seq-R</td>
<td align="left" valign="middle">CATATCAAAGGGAAAACTGTCCA</td>
</tr>
<tr>
<td align="left" valign="middle">CinA -confirm-F</td>
<td align="left" valign="middle">CTCCGTCATGACATCAGGATGC</td>
</tr>
<tr>
<td align="left" valign="middle">CinA -confirm-R</td>
<td align="left" valign="middle">AACGCTAAAGGCGGATGGC</td>
</tr>
<tr>
<td align="left" valign="middle">CinA -inter-F</td>
<td align="left" valign="middle">CAACATCAGTATTTAGCTGCTGCTTAG</td>
</tr>
<tr>
<td align="left" valign="middle">CinA -inter-R</td>
<td align="left" valign="middle">CAGGTCCACCCCGTGAGTTA</td>
</tr>
<tr>
<td align="left" valign="top">Lp2514-real-R</td>
<td align="left" valign="top">CCTGCAGTTAGCTGCCAACTTTCTT</td>
</tr>
<tr>
<td align="left" valign="top">Lp1032-real-F</td>
<td align="left" valign="top">AGCTGACAAGATTGTCGAAACGG</td>
</tr>
<tr>
<td align="left" valign="top">Lp1032-real-R</td>
<td align="left" valign="top">CACGTGAGTCCTTAAACTTATGTGGT</td>
</tr>
<tr>
<td align="left" valign="top">Lp1047-real-F</td>
<td align="left" valign="top">GTAATGCAAGTGCCTAAGCTGGC</td>
</tr>
<tr>
<td align="left" valign="top">Lp1047-real-R</td>
<td align="left" valign="top">CTTCAACTGCTTCGTCTAAGTTTTTAGC</td>
</tr>
<tr>
<td align="left" valign="top">Lp1047-real-F</td>
<td align="left" valign="top">TCGACCGGAGATATCTTCCGT</td>
</tr>
<tr>
<td align="left" valign="top">Lp1047-real-R</td>
<td align="left" valign="top">GTGACTTCGTCTGGTACTAAGTTACCT</td>
</tr>
<tr>
<td align="left" valign="top">Lp2900-real-F</td>
<td align="left" valign="top">CGTCACAACAAGCCATAGATTGTAT</td>
</tr>
<tr>
<td align="left" valign="top">Lp2900-real-R</td>
<td align="left" valign="top">GCGTTCACATCTAAGTTTGTTGCT</td>
</tr>
<tr>
<td align="left" valign="top">Lp2710-real-F</td>
<td align="left" valign="top">TTATTGATTGGCGCGGCC</td>
</tr>
<tr>
<td align="left" valign="top">Lp2710-real-R</td>
<td align="left" valign="top">AACGTTGCGATCCCACACA</td>
</tr>
<tr>
<td align="left" valign="top">Lp2830-real-F</td>
<td align="left" valign="top">ACGTGGCTGAGTTAGTCCG</td>
</tr>
<tr>
<td align="left" valign="top">Lp2830-real-R</td>
<td align="left" valign="top">CCTGAATTATTACATCGACGTCGCT</td>
</tr>
<tr>
<td align="left" valign="top">Lp2771-real-F</td>
<td align="left" valign="top">GTTCCTGACAATGGTAGCTTTGTCA</td>
</tr>
<tr>
<td align="left" valign="top">Lp2771-real-R</td>
<td align="left" valign="top">GACGGAAGTAGTCGAGGTCAC</td>
</tr>
<tr>
<td align="left" valign="top">Lp3556-real-F</td>
<td align="left" valign="top">GCTGCTTCAACTGGTAAGCCAG</td>
</tr>
<tr>
<td align="left" valign="top">Lp3556-real-R</td>
<td align="left" valign="top">GAGCCAGAAAGTATGACGTTGAGTCC</td>
</tr>
<tr>
<td align="left" valign="top">Lp3545-real-F</td>
<td align="left" valign="top">TGCATCTTGGTTAATAGCACCCTTG</td>
</tr>
<tr>
<td align="left" valign="top">Lp3545-real-R</td>
<td align="left" valign="top">ACGTATCGTGGCTCACGG</td>
</tr>
<tr>
<td align="left" valign="top">Lp0230-real-F</td>
<td align="left" valign="top">ACGAATGCAACCCAAAGCG</td>
</tr>
<tr>
<td align="left" valign="top">Lp0230-real-R</td>
<td align="left" valign="top">CGGCATAACCATATTACTTAGTGCAC</td>
</tr>
<tr>
<td align="left" valign="top">Lp2302-real-F</td>
<td align="left" valign="top">GGTACTGCTTGGCCTTCAC</td>
</tr>
<tr>
<td align="left" valign="top">Lp2302-real-R</td>
<td align="left" valign="top">GGTATCAGTTTTACAGGCGTTGC</td>
</tr>
<tr>
<td align="left" valign="top">Lp3555-real-F</td>
<td align="left" valign="top">GACCATAATAGGCACTTGCACCA</td>
</tr>
<tr>
<td align="left" valign="top">Lp3555-real-R</td>
<td align="left" valign="top">ATACTGCGCAATTGACCCGT</td>
</tr>
<tr>
<td align="left" valign="top">Lp2183-real-F</td>
<td align="left" valign="top">GGCATCCTGAATCTGACCAGT</td>
</tr>
<tr>
<td align="left" valign="top">Lp2183-real-R</td>
<td align="left" valign="top">TGGTTGCAACGGCATTCC</td>
</tr>
<tr>
<td align="left" valign="top">Lp2703-real-F</td>
<td align="left" valign="top">CGCCACCATTGCCATCC</td>
</tr>
<tr>
<td align="left" valign="top">Lp2703-real-R</td>
<td align="left" valign="top">ATGCGATTATCATGCATCCGGC</td>
</tr>
<tr>
<td align="left" valign="top">Lp2251-real-F</td>
<td align="left" valign="top">TGGCTTCCTTAGTTGGAATCGATG</td>
</tr>
<tr>
<td align="left" valign="top">Lp2251-real-R</td>
<td align="left" valign="top">TGCACTCAGTTCGGTCTTAATGC</td>
</tr>
<tr>
<td align="left" valign="top">Ter-P23-F</td>
<td align="left" valign="top">GAGACGGATGATTAAGAATTCAGTGATTAGTCAAAGAATGGTGATGACA</td>
</tr>
<tr>
<td align="left" valign="top">Ter-P23-R</td>
<td align="left" valign="top">AGCGAAGCGAACACTTGATTTTT</td>
</tr>
<tr>
<td align="left" valign="top">p23-lp2514-F</td>
<td align="left" valign="top">AATCAAGTGTTCGCTTCGCTCGAAAAGCCCTGACAACCCT</td>
</tr>
<tr>
<td align="left" valign="top">p23-lp2514-R</td>
<td align="left" valign="top">ATCGATAGATCTCGAGCTCTATTAATCATCCGTCTCTTGATTCGG</td>
</tr>
<tr>
<td align="left" valign="top">orf1015-F</td>
<td align="left" valign="top">AATGACAATGATGTTGGATCCTTGAAAATAAAAAAATATGCAGCAT</td>
</tr>
<tr>
<td align="left" valign="top">orf1015-R</td>
<td align="left" valign="top">AGATCTCGAGCTCTAGAATTCTTACTTATCAATGCTTAGTT</td>
</tr>
<tr>
<td align="left" valign="top">LLNZ00315-F</td>
<td align="left" valign="top">AATGACAATGATGTTGGATCCATGATTAAACAATTTTTAGGTATTATTAACTCAG</td>
</tr>
<tr>
<td align="left" valign="top">LLNZ00315-R</td>
<td align="left" valign="top">AGATCTCGAGCTCTAGAATTCTTAATTCTTTTTATCTACCAAATCTAAAAGGA</td>
</tr>
<tr>
<td align="left" valign="top">p23-lp2514-R1</td>
<td align="left" valign="top">ACCATTCTTTGACTAATCACTTTAATCATCCGTCTCTTGATTCGG</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The homologous arms of <italic>lp2514</italic> were amplified from WCFS1. The specific guide RNA (gRNA), composed of a 20&#x202F;bp protospacer sequence, was cloned from pLCP using gRNA-lp2514-F/gRNA-lp2514-R primers (<xref ref-type="bibr" rid="ref7">Huang et al., 2019</xref>). The plasmid pLCP (CRISPR/Cas9 system) was digested with the restriction enzymes <italic>Apa</italic> I and <italic>Xba</italic> I, and then ligated to the fragments using the ClonExpress one-step cloning kit, resulting in the creation of recombinant plasmid pLXY07 for <italic>lp2514</italic> gene knockout. The pHH13 plasmid was constructed as described above.</p>
</sec>
<sec id="sec5">
<label>2.3</label>
<title>Genome manipulation procedures using CRISPR/Cas9 in <italic>Lactiplantibacillus plantarum</italic></title>
<p>The competent cells of <italic>L. plantarum</italic> WCFS1 were generated in accordance with previous report (<xref ref-type="bibr" rid="ref7">Huang et al., 2019</xref>). The helper plasmid pLH01 was transformed into <italic>L. plantarum</italic> WCFS1, and the resulting positive transformants were screened on Cm plates for the preparation of the competent cells. The plasmid pLXY07 was subsequently transferred into WCFS1 via electroporation, and cultivated for 72&#x202F;h at 37&#x00B0;C. To confirm positive recombinants, colony PCR analysis was performed using the primers (lp2514-confirm-F/lp2514-confirm-R; lp2514-inter -F/lp2514-inter -R) that targeted the homologous regions of the <italic>lp2514</italic> gene. After successful genome editing, the recombinant strain was serially passaged without antibiotics for 2&#x2013;3 generations to facilitate plasmid curing. Colonies were screened for the loss of antibiotic resistance, and plasmid loss was further confirmed by colony PCR.</p>
</sec>
<sec id="sec6">
<label>2.4</label>
<title>Fermentation of engineered <italic>Lactiplantibacillus plantarum</italic> for <italic>lp2514</italic> expression and NMN production</title>
<p>The plasmids pLXY04, pLXY09, pLXY10 and pKLH32 (as a control) were introduced into <italic>L. plantarum</italic> WCFS1. The engineered <italic>L. plantarum</italic> WCFS1 and WCFS1&#x0394;<italic>lp2514</italic> strains were grown at 37&#x00B0;C. Cell growth was quantified by measuring optical density at 600&#x202F;nm (OD 600&#x202F;nm) with a UV&#x2013;Vis spectrophotometer. The fermentation broths were collected by centrifugation (12,000 <italic>g</italic>, 10&#x202F;min, 4&#x00B0;C), and the cells were resuspended in buffer solution for disruption using a low temperature ultrahigh-pressure continuous flow cell disrupter. The resulting cell lysate was then centrifuged (12,000 <italic>g</italic>, 3&#x202F;min, 4&#x00B0;C), and the supernatants were decanted for the NMN assay. NMN was derived from <italic>L. plantarum</italic> and detected with reported fluorometric methods (<xref ref-type="bibr" rid="ref12">Kong et al., 2023</xref>; <xref ref-type="bibr" rid="ref19">Marinescu et al., 2018</xref>).</p>
</sec>
<sec id="sec7">
<label>2.5</label>
<title>Real-time quantitative PCR (RT-qPCR) assay</title>
<p>Total RNA was extracted from <italic>L. plantarum</italic> WCFS1/pKLH32, WCFS1/pLXY04, WCFS1/pLXY09, and WCFS1/pLXY10 using the RNAiso Plus reagent (TaKaRa, Japan) following the manufacturer&#x2019;s protocol. First-strand cDNA was synthesized from 1&#x202F;&#x03BC;g of total RNA using a reverse transcription kit. GAPDH was used as the internal control, and relative transcript levels were calculated using the 2<sup>^&#x2212;&#x0394;&#x0394;Ct</sup> method.</p>
</sec>
<sec id="sec8">
<label>2.6</label>
<title>RNA-sequencing and transcriptomic analysis</title>
<p>Total RNA was extracted from <italic>L. plantarum</italic> strains WCFS1/pLXY04 (<italic>lp2514</italic> overexpression with 0.1% NAM) and WCFS1/pKLH32 (empty vector control with 0.1% NAM) using RNAiso Plus reagent (TaKaRa, Japan) following the manufacturer&#x2019;s instructions. RNA purity and concentration were assessed using a NanoDrop spectrophotometer (Thermo Fisher Scientific, United States), and RNA integrity was verified via agarose gel electrophoresis and an Agilent 2,100 Bioanalyzer (Agilent Technologies, United States). Sequencing was conducted on an Illumina HiSeq 2000 platform (Majorbio Bio-Pharm Technology Co., Ltd., Shanghai, China). Clean reads were mapped to the reference genome of <italic>L. plantarum</italic> WCFS1, and gene expression levels were quantified as fragments per kilobase of transcript per million mapped reads (FPKM). Differentially expressed genes (DEGs) between the two groups (N04 vs. N32) were identified using DESeq2 software with thresholds of |log&#x2082;Fold Change| &#x2265; 1 and adjusted <italic>p</italic>-value (FDR) &#x003C; 0.05. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed to investigate functional categories and metabolic pathways significantly affected by <italic>lp2514</italic> overexpression.</p>
</sec>
<sec id="sec9">
<label>2.7</label>
<title>Statistical analysis</title>
<p>All the experimental data were independently repeated in triplicate. Statistical analyses of the data were performed with GraphPad Prism and are presented as the means &#x00B1; standard deviations (&#x002A;<italic>p</italic> &#x003C;&#x202F;0.05 and &#x002A;&#x002A;<italic>p</italic> &#x003C;&#x202F;0.01).</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="sec10">
<label>3</label>
<title>Results and discussion</title>
<sec id="sec11">
<label>3.1</label>
<title>Screening NAM transporter for NMN biosynthesis from LAB</title>
<p>The efficient biosynthesis of NMN by LAB using NAM as the substrate was shown to be an effective synthesis strategy in our previous study (<xref ref-type="bibr" rid="ref12">Kong et al., 2023</xref>). The translocation of the NAM substrate into the host cell to increase NMN production requires a robust NAM transporter (<xref ref-type="fig" rid="fig1">Figure 1</xref>). However, there have been no reports on the endogenous proteins responsible for transporting NAM in LAB. Native proteins are more favorable for expression within the host. NiaP from <italic>Burkholderia cenocepacia</italic> significantly improved NAM uptake leading to an enhance in the synthesis of NMN from 185&#x202F;mg&#x202F;L<sup>&#x2212;1</sup> to 231&#x202F;mg&#x202F;L<sup>&#x2212;1</sup> (<xref ref-type="bibr" rid="ref23">Shoji et al., 2021</xref>). <italic>In silico</italic> analysis revealed the presence of putative NAM transporters in LAB, including <italic>L. plantarum, L. lactis and S. thermophilus.</italic> Using BCNiaP as a query sequence for BLAST analysis with the target genomes, the genes encoding <italic>orf1015</italic> from <italic>S. thermophilus</italic> S-3, <italic>LLNZ00315</italic> from <italic>L. lactis</italic> NZ9000 and <italic>lp2514</italic> from <italic>L. plantarum</italic> WCFS1 were identified. Phylogenetic tree analysis showed that the NiaP from different sources clustered into distinct branches, and that <italic>lp2514</italic> from <italic>L. plantarum</italic> WCFS1 was positioned in close proximity to BCNiaP (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The above genes were subsequently inserted into the pKLH32 plasmid, and the resulting plasmids were transferred to <italic>L. plantarum</italic> WCFS1 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Among these strains, strain WCFS1/pLXY04, which expressed <italic>lp2514</italic> could biosynthesize 89.6&#x202F;&#x03BC;mol&#x202F;L<sup>&#x2212;1</sup> of NMN intracellularly, resulting in 62.3% increase in NMN levels, compared with those of strain WCFS1/pKLH32, which contained only the empty plasmid of pKLH32 (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). These results clearly demonstrate that the expression of NiaP (<italic>lp2514</italic>) facilitates the production of NMN in <italic>L. plantarum</italic>, which is consistent with the phylogenetic tree. The <italic>lp2514</italic> gene markedly affected the NMN yield and was applied for subsequent experiments.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Screening of niacin transporters for NMN production in lactic acid bacteria. Phylogenetic analysis of NAM transporters in LAB <bold>(A)</bold>. Schematic representation of recombinant expression plasmids containing orf1015 from <italic>S. thermophilus</italic> S-3, LLNZ00315 from <italic>L. lactis</italic> NZ9000 and <italic>lp2514</italic> from WCFS1 <bold>(B)</bold>. The ability of different recombinant strains expressing NiaP to synthesize NMN <bold>(C)</bold>. &#x002A;<italic>p</italic> &#x003C; 0.05 , &#x002A;&#x002A;<italic>p</italic> &#x003C; 0.01.</p>
</caption>
<graphic xlink:href="fmicb-16-1637666-g002.tif">
<alt-text content-type="machine-generated">Phylogenetic tree, plasmid map, and bar chart displaying niacin transporter data. (A) Phylogenetic tree shows relationships among NiaP, lp2514, LLNZ00315, and orf1015, with lp2514 highlighted. (B) Plasmid map of pKLH32-Niap, indicating gene locations and restriction sites. (C) Bar chart compares NMN production among Control, LLNZ00315, orf1015, and lp2514, with lp2514 showing significantly higher production.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec12">
<label>3.2</label>
<title>Identification of the <italic>lp2514</italic> gene via <italic>in silico</italic> molecular docking and CRISPR/Cas9 technology</title>
<p>We performed domain analysis of the NAM transporter using the search tool for conserved domains from the NCBI, and reported that BCNiaP and <italic>lp2514</italic> possessed the same domains as MFS_SV2_like, UhpC and MFS_1, suggesting that <italic>lp2514</italic> has the potential to conjugate NAM to NMN. The MFS transporter (UniProt A0A2R3JML5; seq similarity 53%; coverage 98%) was selected as template for homology modeling of <italic>lp2514</italic> (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The Ramachandran plot revealed that all the residues were predominantly in the most favored region (96.4%) and in an additional allowable area (3.6%), suggesting that the conformation of the generated model adheres to principles of stereochemistry (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>). The structural models of <italic>lp2514</italic> could be applied to simulate molecular docking with the substrate NAM molecule being docked in the substrate binding pocket of <italic>lp2514</italic> using a docking server. The key residues of ASP140, TRP19, TRP318, and ILE322 were located close to the substrate NAM (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). These findings suggest that the lp2514 protein has strong binding affinity for the NAM substrate.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Structural model of <italic>lp2514</italic> and the key residues close to NAM. <italic>In silico</italic> tertiary structure modeling results for the lp2514 protein using the SWISS-MODEL server <bold>(A)</bold>. <italic>In silico</italic> molecular docking of NAM to lp2514 was simulated by docking server, and the residues (ASP140, TRP19, TRP318, and ILE322) are shown in stick format <bold>(B)</bold>.</p>
</caption>
<graphic xlink:href="fmicb-16-1637666-g003.tif">
<alt-text content-type="machine-generated">Molecular visualizations of a protein structure. Panel A shows a three-dimensional ribbon diagram with colorful helices interwoven. Panel B displays a close-up view highlighting specific amino acids, labeled as ASP40, TRP19, TRP318, and ILE322, with green, red, and blue markers indicating structural details.</alt-text>
</graphic>
</fig>
<p>Considering the potential role of the <italic>lp2514</italic> gene in promoting NMN biosynthesis via NAM uptake, it was worthwhile to verify its functionality by knockout of <italic>lp2514</italic> via CRISPR/Cas9 technology in <italic>L. plantarum</italic> WCFS1 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). A pLXY07 plasmid was constructed to develop the gene deletion mutant of <italic>lp2514</italic>, which was subsequently delivered into WCFS1 (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2</xref>). One positive mutant (WCFS1&#x0394;<italic>lp2514</italic>) was successfully generated from eight transformants via colony PCR (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). The acquisition of a deletion was verified by sequencing the PCR amplification product of the <italic>lp2514</italic> mutant (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). When 1&#x202F;g&#x202F;L<sup>&#x2212;1</sup> NAM was added, the intracellular NMN production of WCFS1&#x0394;<italic>lp2514</italic> was decreased by 17% compared with that of the wild-type WCFS1 (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Interestingly, when <italic>lp2514</italic> was overexpressed in the WCFS1&#x0394;<italic>lp2514</italic> strain, NMN production was restored. These findings revealed that the <italic>lp2514</italic> gene plays a role as NAM transporter affecting the biosynthesis of NMN, which agrees well with our above results. This is the first report on newly developed NAM transporter screening for NMN biosynthesis in LAB.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Characterization of the effects of <italic>lp2514</italic> on NMN biosynthesis via CRISPR/Cas9 in <italic>L. plantarum</italic> WCFS1. Schematic representation of the pH01 and pLXY07 plasmids used for <italic>lp2514</italic> gene knockout <bold>(A)</bold>. Identification of <italic>lp2514</italic> deletion using colony PCR <bold>(B)</bold>. The wild-type WCFS1 was used as control. The 2.1 and 3.3-kb bands indicate the positive and negative mutants, respectively. 1&#x2013;7: transformants; 8&#x2013;9: Wild-type. Sequencing validation of the WCFS1&#x0394;<italic>lp2514</italic> mutant <bold>(C)</bold>. Intracellular NMN production of WCFS1&#x0394;<italic>lp2514</italic> mutant and WCFS1&#x0394;<italic>lp2514/p23-lp2514</italic> strains <bold>(D)</bold>.</p>
</caption>
<graphic xlink:href="fmicb-16-1637666-g004.tif">
<alt-text content-type="machine-generated">Panel A shows a schematic of a CRISPR-Cas9 system with guide sequence and labeled genetic components. Panel B displays a gel electrophoresis image with lanes marked from M to 9, showing DNA bands around 2000-3000 bp. Panel C features DNA sequencing results with nucleotide sequences and peaks. Panel D presents a bar graph comparing NMN production in three samples, labeled WCF51, WCF51&#x0394;lp2514, and WCF51&#x0394;lp2514/P&#x2097;&#x2082;&#x2083;-lp2514, with values around 60-80 &#x03BC;mol/L.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec13">
<label>3.3</label>
<title>Effect of <italic>lp2514</italic> on NMN biosynthesis via NAM uptake in <italic>Lactiplantibacillus plantarum</italic></title>
<p>To evaluate whether WCFS1/pLXY04 could increase in NMN production, various substrate concentrations of NAM and fermentation durations were tested. Overexpression of <italic>lp2514</italic> did not affect the growth of the recombinant strains WCFS1/pKLH32 and WCFS1/pLXY04 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). <xref ref-type="bibr" rid="ref12">Kong et al. (2023)</xref> reported that various NAM concentrations had an impact on the growth of <italic>L. lactis</italic> NZ9000, under high concentration conditions (50&#x202F;g&#x202F;L<sup>&#x2212;1</sup>), NAM inhibited strain growth. The utilization of 50&#x202F;g&#x202F;L<sup>&#x2212;1</sup> NAM exhibited toxicity toward recombinant <italic>E. coli</italic> (<xref ref-type="bibr" rid="ref19">Marinescu et al., 2018</xref>). The growth of WCFS1/pKLH32 and WCFS1/pLXY04 was not limited by the addition of 1&#x202F;g&#x202F;L<sup>&#x2212;1</sup> or 5&#x202F;g&#x202F;L<sup>&#x2212;1</sup> NAM, although a slight decrease in the growth rate was observed with 10&#x202F;g&#x202F;L<sup>&#x2212;1</sup> NAM. This finding is consistent with the findings of our previous study (<xref ref-type="bibr" rid="ref12">Kong et al., 2023</xref>). Moreover, the growth rates are closely associated with the consumption of glucose (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). NAM addition is a limiting factor for NMN biosynthesis, and various researchers have added different doses of NAM when is utilized NiaP (<xref ref-type="bibr" rid="ref9">Jeanguenin et al., 2012</xref>; <xref ref-type="bibr" rid="ref23">Shoji et al., 2021</xref>; <xref ref-type="bibr" rid="ref24">Su et al., 2024</xref>). Compared with the control WCFS1/pKLH32, WCFS1/pLXY04 achieved significant NMN production, where varying amounts of NAM (1, 5 and 10&#x202F;g&#x202F;L<sup>&#x2212;1</sup>) were supplied to the MRS medium (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). The maximum intracellular NMN titer of WCFS1/pLXY04 (155.5&#x202F;&#x03BC;mol&#x202F;L<sup>&#x2212;1</sup>; 1&#x202F;g&#x202F;L<sup>&#x2212;1</sup> NAM) was synthesized after 12&#x202F;h of fermentation, which was 182.7% greater than that of the control (55&#x202F;&#x03BC;mol&#x202F;L<sup>&#x2212;1</sup>) without NAM supplementation. <xref ref-type="bibr" rid="ref19">Marinescu et al. (2018)</xref> reported that the addition of 1&#x202F;g&#x202F;L<sup>&#x2212;1</sup> NAM resulted in the greatest NMN accumulation, which is consistent with our findings. These findings revealed that relatively high concentrations of NAM may not be conducive to NMN accumulation.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Effects of the NMN transporter <italic>lp2514</italic> on NMN biosynthesis. The growth curves (OD 600&#x202F;nm) <bold>(A)</bold> and remaining glucose <bold>(B)</bold> of <italic>lp2514</italic> gene expression recombinants in MRS media supplemented with 0, 1, 5 and 10&#x202F;g&#x202F;L<sup>&#x2212;1</sup> NAM. Effect of NAM concentration (0, 1, 5 and 10&#x202F;g&#x202F;L<sup>&#x2212;1</sup>) on NMN production by recombinant <italic>L. plantarum</italic> WCFS1/pLXY04 <bold>(C)</bold>. Effects of the different fermentation time (12, 24, and 36&#x202F;h) on NMN production in MRS media supplemented with 1&#x202F;g&#x202F;L<sup>&#x2212;1</sup> NAM <bold>(D)</bold>. &#x002A;<italic>p</italic> &#x003C; 0.05 , &#x002A;&#x002A;<italic>p</italic> &#x003C; 0.01.</p>
</caption>
<graphic xlink:href="fmicb-16-1637666-g005.tif">
<alt-text content-type="machine-generated">Graphs comparing OD 600nm and glucose consumption over 36 hours for different concentrations (0%, 0.1%, 0.5%, 1%) of pKLH32 and pLXY04. The top right bar graph shows NMN production under these conditions, highlighting differences with significance indicated (&#x002A;&#x002A; for p&#x003C;0.01, &#x002A; for p&#x003C;0.05). The bottom right bar graph displays NMN production at 12, 24, and 36 hours for both plasmids, also indicating significance.</alt-text>
</graphic>
</fig>
<p>To determine the appropriate fermentation time for enhanced NMN production, the effects of fermentation for various time periods (12, 24 and 36&#x202F;h) on NMN biosynthesis were evaluated, and the results indicated that fermentation times of 24&#x202F;h (168.9&#x202F;&#x03BC;mol&#x202F;L<sup>&#x2212;1</sup>) or longer were was suitable for the biosynthesis of NMN (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). <xref ref-type="bibr" rid="ref25">Sugiyama et al. (2021)</xref> reported that <italic>Fructobacillus tropaeoli</italic> RD012354 presented the highest NMN production after 24&#x202F;h cultivation. These findings revealed that the recombinant strain WCFS1/pLXY04, when cultured under optimized conditions (1&#x202F;g&#x202F;L<sup>&#x2212;1</sup> NAM and 24&#x202F;h cultivation), resulted in a 207% increase in the NMN yield, reaching 168.9&#x202F;&#x03BC;mol&#x202F;L<sup>&#x2212;1</sup>.</p>
</sec>
<sec id="sec14">
<label>3.4</label>
<title>Multi-copy expression of <italic>lp2514</italic> unlock high-efficiency NMN biosynthesis in <italic>Lactiplantibacillus plantarum</italic></title>
<p>The multicopy expression cassette strategy represents a robust approach to increase natural product yields by increasing recombinant protein abundance, albeit with potential metabolic trade-offs. <xref ref-type="bibr" rid="ref4">Cheng et al. (2023)</xref> employed a multicopy integration strategy to increase the production of germacrene A, which resulted in a 7.7-fold increase over the control. An optimal number of gene copies should be carefully studied because of the metabolic pressure associated with protein overexpression. To enhance the expression of <italic>lp2514</italic>, multicopy expression plasmids were constructed based on the pKLH32 vector. The <italic>lp2514</italic> gene was amplified using overlap extension PCR and inserted sequentially into the <italic>Bam HI</italic>/<italic>Eco</italic> RI sites of pKLH32 to generate plasmids harboring one (pLXY04), two (pLXY09), and three (pLXY10) tandem copies of <italic>lp2514</italic> under the control of the same promoter (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Compared with that of WCFS1/pKLH32, the OD<sub>600</sub> value of WCFS1/pLXY09 significantly decreased during 36&#x202F;h cultivation, accompanied by a simultaneous reduction in the rate of glucose consumption (<xref ref-type="fig" rid="fig6">Figures 6A</xref>,<xref ref-type="fig" rid="fig6">B</xref>). The expression of multiple <italic>lp2514</italic> imposed a certain burden on the growth of the strain. Notably, an obviously greater quantity of NMN (203&#x202F;&#x03BC;mol&#x202F;L<sup>&#x2212;1</sup>) was substantiated by WCFS1/pLXY09 expressing two copies of <italic>lp2514</italic>, which increased by 37 and 85% compared with those of WCFS1/pKLXY04 and WCFS1/pKLH32, respectively (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). <xref ref-type="bibr" rid="ref13">Kong et al. (2020)</xref> reported that dual-copy families of the SOD, not four-copy families, presented the greatest activity, with a similar conclusion. The NMN production of WCFS1/pLXY10 also increased by 42% compared with that of the control strain (WCFS1/pKLH32), but slightly decreased compared with that of WCFS1/pLXY09. It is possible that <italic>lp2514</italic> overexpression in multiple copies may cause metabolic stress, which subsequently affects NMN biosynthesis. Compared with that of the control WCFS1/pKLH32 without NAM, the final NMN titer was increased by 269% via a series of regulatory mechanisms. The accumulation of NMN in WCFS1/pLXY09 was approximately 33.9-fold greater than that in <italic>Fructobacillus durionis</italic> RD011727 (<xref ref-type="table" rid="tab3">Table 3</xref>). Moreover, the transcriptional analysis revealed a significant increase in the expression of <italic>lp2514</italic> in multicopy recombinants, exceeding that of the control strain by more than 1,000-fold (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). The gene copy number is strongly correlated with the transcriptional level of <italic>lp2514</italic>, rather than with NMN production. This achievement represents the highest reported yield of NMN using NAM as substrate in <italic>L. plantarum</italic>, marking a significant advancement in the field of NMN biosynthesis by LAB. Although the yield of NMN synthesized has reached g L<sup>&#x2212;1</sup> levels (17.2&#x202F;g&#x202F;L<sup>&#x2212;1</sup>) by <italic>E. coli</italic>, which are much greater than those of LAB (<xref ref-type="bibr" rid="ref17">Maharjan et al., 2023</xref>), our <italic>L. plantarum</italic> platform retains distinct benefits for functional-food applications. Specifically, <italic>L. plantarum</italic> has GRAS status, an intrinsic probiotic effect (supporting gut health and immune modulation), and the ability to perform food-grade fermentations without extensive downstream purification. These properties make LAB particularly well suited for developing NMN &#x2013; enriched fermented products that can be marketed directly to health &#x2013; conscious consumers. This study establishes <italic>lp2514</italic> multicopy engineering as a transformative strategy for LAB-based NMN bioproduction, bridging synthetic biology with functional food innovation.</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>Expression of multicopy <italic>lp2514</italic> in <italic>L. plantarum</italic> WCFS1. The growth curves (OD600 nm) <bold>(A)</bold> and remaining glucose <bold>(B)</bold> of multicopy-lp2514 gene expression recombinants supplemented with 1&#x202F;g&#x202F;L<sup>&#x2212;1</sup> NAM. Construction of plasmids with increasing copy numbers of the <italic>lp2514</italic> expression cassette, and analysis of the production of NMN in recombinants <bold>(C)</bold>. Analysis of the expression level by RT-qPCR in <italic>L. plantarum</italic> WCFS1 recombinants <bold>(D)</bold>. &#x002A;&#x002A;<italic>p</italic> &#x003C; 0.01 , &#x002A;&#x002A;&#x002A;<italic>p</italic> &#x003C; 0.0001.</p>
</caption>
<graphic xlink:href="fmicb-16-1637666-g006.tif">
<alt-text content-type="machine-generated">A set of graphs illustrating various experimental data. (A) Line graph showing OD 600 nm over time for four plasmids: pKLH32, pLXY04, pLXY09, and pLXY10. The growth curves plateau after 8 hours.(B) Line graph depicting glucose concentration over time for pKLH32-glu, pLXY04-glu, pLXY09-glu, and pLXY10-glu. Glucose levels decline significantly until steadied around 24 hours.(C) Schematic representation of genetic constructs with a corresponding bar graph indicating NMN production in micromoles per liter. pLXY10 shows the highest NMN production.(D) Bar graph comparing the relative expression of pKLH32, pLXY04, pLXY09, and pLXY10. pLXY10 exhibits the highest expression, with statistical significance indicated by asterisks.</alt-text>
</graphic>
</fig>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Comparison of NMN titer levels of different lactic acid bacteria strains.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Strains</th>
<th align="left" valign="top">NMN titer</th>
<th align="left" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top"><italic>Fructobacillus tropaeoli</italic> RD012353</td>
<td align="left" valign="top">1.5&#x202F;mg&#x202F;L<sup>&#x2212;1</sup></td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref25">Sugiyama et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Fructobacillus tropaeoli</italic> RD012354</td>
<td align="left" valign="top">1&#x202F;mg&#x202F;L<sup>&#x2212;1</sup></td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref25">Sugiyama et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Fructobacillus durionis</italic> RD011727</td>
<td align="left" valign="top">2&#x202F;mg&#x202F;L<sup>&#x2212;1</sup></td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref25">Sugiyama et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>L. plantarum</italic> WCFS1</td>
<td align="left" valign="top">203&#x202F;&#x03BC;mol&#x202F;L<sup>&#x2212;1</sup> (67.8&#x202F;mg&#x202F;L<sup>&#x2212;1</sup>)</td>
<td align="left" valign="top">This study</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec15">
<label>3.5</label>
<title>Transcriptomic analysis of NMN biosynthesis pathways in <italic>lp2514</italic>-overexpressing <italic>Lactiplantibacillus plantarum</italic></title>
<sec id="sec16">
<label>3.5.1</label>
<title>Screening of DEGs</title>
<p>To elucidate the transcriptional response of <italic>L. plantarum</italic> to <italic>lp2514</italic> overexpression in the presence of NAM, we conducted RNA-seq analysis comparing strain N04 (overexpressing <italic>lp2514</italic>) with N32 (empty vector control) (<xref ref-type="fig" rid="fig7">Figure 7</xref>). The Venn diagram highlights 29 unique DEGs in N04, suggesting specific regulatory targets of <italic>lp2514</italic> (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). The DEGs are likely directly related to <italic>lp2514</italic> overexpression, further supporting its pivotal role in NMN biosynthesis. Volcano plot analysis revealed that 332 genes were significantly upregulated and that 266 genes were downregulated (|log2FC| &#x003E; 1, FDR &#x003C; 0.05) in N04 (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Each point represents a gene, with red indicating upregulation, blue indicating downregulation, and gray denoting no significant expression change. The upregulated genes are likely associated with NMN biosynthesis pathways, whereas the downregulated genes may pertain to competing metabolic pathways.</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>Transcriptomic profiling of <italic>lp2514</italic>-overexpressing <italic>L. plantarum</italic> (N04) versus control (N32). Venn diagram illustrating unique and shared genes between N04 and N32 <bold>(A)</bold>. Volcano plot of differentially expressed genes (DEGs). Significantly upregulated (332 genes, red; |log2FC| &#x003E;1, FDR &#x003C;0.05) and downregulated (266 genes, blue) genes are highlighted <bold>(B)</bold>.</p>
</caption>
<graphic xlink:href="fmicb-16-1637666-g007.tif">
<alt-text content-type="machine-generated">A Venn diagram and volcano plot are shown. The Venn diagram compares N32 and N04, with 23 and 26 unique elements and 3,023 overlapping elements. The volcano plot (N04 vs N32) displays gene expression data, highlighting significant differentially expressed genes: 332 upregulated in red, 266 downregulated in blue, and 2,521 not significant in grey. The x-axis represents Log2 fold change, while the y-axis shows the negative log of adjusted p-values.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec17">
<label>3.5.2</label>
<title>GO analysis reveals functional rewiring toward NMN biosynthesis</title>
<p>GO annotation revealed that the overexpression of <italic>lp2514</italic> in the N04 strain significantly alters the representation of gene categories compared to the N32 strain (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). Notably, there is an increase in the number of DEGs associated with &#x201C;transporter activity&#x201D; and &#x201C;catalytic activity&#x201D; in N04, suggesting an enhanced capacity for the absorption of NAM and its conversion into NMN. Furthermore, elevated counts in categories &#x201C;translation&#x201D; and &#x201C;structural constituent of ribosome&#x201D; suggest a system-wide enhancement of the protein synthesis machinery, which is consistent with an increased demand for NMN-biosynthetic enzymes. GO enrichment analysis (represented as a bubble plot) identifies specific processes that were most strongly upregulated in N04 (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). &#x201C;Transporter activity&#x201D; had the lowest adjusted <italic>p</italic>-value and a moderately rich factor, underscoring <italic>lp2514</italic>&#x2019;s direct role in NAM import. There was a marked overrepresentation of biological processes related to peptide biosynthesis (rich factor = 0.65) and ribosome assembly (rich factor = 0.7) in N04 compared with N32. This is consistent with the 332 upregulated genes identified in the volcano plot, many of which encode ribosomal proteins, such as <italic>rpsJ</italic> and <italic>rplE</italic>. The enrichment of ribosome-associated terms indicates a potential connection to the efficient expression of enzymes required for NMN biosynthesis, while the increased activity of structural molecules may offer metabolic support to the cell.</p>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption>
<p>Gene Ontology (GO) annotation and enrichment analysis of N04 vs. N32. GO annotation summary of differentially expressed genes (DEGs) between N04 and N32 <bold>(A)</bold>. GO enrichment bubble plot showing significantly overrepresented GO terms in N04 vs. N32 <bold>(B)</bold>.</p>
</caption>
<graphic xlink:href="fmicb-16-1637666-g008.tif">
<alt-text content-type="machine-generated">Bar and dot plots illustrating GO annotations and enrichment analyses. The top bar plot (A) shows the number of genes across several biological processes, comparing downregulated and upregulated mRNA in N04 vs N32 samples, categorized by biological, cellular, and molecular functions. The bottom dot plot (B) depicts GO enrichment analysis for N04 vs N32 mRNA with GO terms on the y-axis, rich factor on the x-axis, and dot size indicating the number of genes. Colors represent adjusted p-values.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec18">
<label>3.5.3</label>
<title>KEGG analysis reveals functional rewiring toward NMN biosynthesis</title>
<p>The KEGG annotation bar chart supports this metabolic transition, demonstrating that the majority of DEGs are associated with metabolism-related categories, such as &#x201C;carbohydrate metabolism&#x201D; (46 genes) and &#x201C;amino acid metabolism&#x201D; (31 genes), which dominate the profile, whereas non-metabolic categories are considerably smaller (<xref ref-type="fig" rid="fig9">Figure 9A</xref>). KEGG pathway enrichment analysis of the N04 vs. N32 transcriptomes revealed a coordinated reprogramming of core metabolic and translational pathways, which was consistent with increased NMN production (<xref ref-type="fig" rid="fig9">Figure 9B</xref>). The KEGG enrichment analysis further uncovered significant metabolic pathways in N04, including those related to ribosomes, fatty acid biosynthesis, and alanine, aspartate, and glutamate metabolism. The notable enrichment of ribosome pathways is in an agreement with the results of the GO analysis, highlighting the essential role of ribosomes in NMN biosynthesis. The upregulation of fatty acid biosynthesis may reflect increased synthesis of NADPH, a key cofactor for NMN assembly, which is facilitated by the reductive power generated through acetyl-CoA carboxylase activity. <xref ref-type="bibr" rid="ref27">Xiong et al. (2025)</xref> demonstrated that engineering the NMN biosynthesis-related pathway led to a 73% increase in NADPH levels and redirected carbon flux toward NMN biosynthesis, thereby enhancing precursor availability for nucleotide assembly. Furthermore, the enrichment of alanine, aspartate, and glutamate metabolism suggests a metabolic shift toward the production of aspartate-derived precursors for the NAD<sup>+</sup> salvage pathway, directly linking amino acid flux to NMN yield. Collectively, these findings demonstrate that <italic>lp2514</italic> overexpression significantly alters the transcriptome of <italic>L. plantarum</italic>, optimizing metabolic pathways associated with NMN biosynthesis. This research provides a scientific basis for employing <italic>L. plantarum</italic> as a host for NMN production and lays the groundwork for future industrial applications.</p>
<fig position="float" id="fig9">
<label>Figure 9</label>
<caption>
<p>KEGG classification and enrichment of differentially expressed genes in N04 vs. N32. KEGG pathway annotation of DEGs between N04 and N32 <bold>(A)</bold>. KEGG pathway enrichment analysis of DEGs between N04 and N32 <bold>(B)</bold>. Each bubble represents a significantly enriched pathway, with the size corresponding to the number of DEGs and the color indicating the adjusted <italic>p</italic>-value.</p>
</caption>
<graphic xlink:href="fmicb-16-1637666-g009.tif">
<alt-text content-type="machine-generated">Two charts are shown: (A) A bar chart displaying KEGG annotation analysis with categories like signal transduction and metabolism, involving N04 and N32 mRNA groups. (B) A bubble chart depicting KEGG enrichment analysis for N04 vs. N32 mRNA, highlighting pathways like ribosome, fatty acid biosynthesis, and alanine metabolism. Bubble size represents the number of genes, and color indicates adjusted p-values.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="sec19">
<label>3.6</label>
<title>Validation of DEG expression levels via RT-qPCR</title>
<p>To validate the reliability of the RNA-seq data, a subset of DEGs (upregulated, downregulated) identified between N04 and N32 was selected for RT-qPCR analysis (<xref ref-type="table" rid="tab2">Table 2</xref>). Genes were chosen on the basis of their fold change values, involvement in NAD<sup>+</sup> metabolism, and relevance to membrane transport processes as indicated by GO and KEGG enrichment analyses. The RT-qPCR results were strongly concordant with the RNA-Seq data (Spearman&#x2019;s <italic>r</italic> = 0.93, <italic>p</italic> &#x003C; 0.0001), confirming the upregulation of key transport-related genes and NAD<sup>+</sup> biosynthesis genes in the N04 strain (<xref ref-type="table" rid="tab4">Table 4</xref>). Notably, <italic>lp3556</italic> (encoding L-ribulokinase) exhibited a substantial upregulation (RNA-seq = 3.47; RT-qPCR = 3.66), suggesting a shift toward ribulose metabolism potentially linked to enhanced precursor availability for NMN biosynthesis. The key upregulated genes included ribosomal subunits (<italic>lp1032</italic>, RNA-seq = 1.61; RT-qPCR = 1.89) and NAD<sup>+</sup> salvage enzymes (<italic>lp2830</italic> = 2.71; RT-qPCR = 2.54), which directly support enhanced translational capacity and aspartate-derived precursor supply for NMN biosynthesis. Strikingly, <italic>lp2703</italic>, which is involved in aspartate carbamoyltransferase activity, was markedly downregulated (RNA-seq = &#x2212;2.27; RT-qPCR = &#x2212;1.74), possibly reflecting alterations in pyrimidine biosynthesis under <italic>lp2514</italic>-mediated conditions. Together, the RT-qPCR results were consistent with the RNA-seq data, confirming the transcriptional regulation of key metabolic nodes.</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>Validation of DEGs in <italic>lp2514</italic>-overexpressing <italic>L. plantarum</italic> via RT-qPCR.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" rowspan="2">Gene ID</th>
<th align="left" valign="top" rowspan="2">Description</th>
<th align="center" valign="top" colspan="2">Fold change (N04 vs. N32) Log<sub>2</sub>FC</th>
</tr>
<tr>
<th align="center" valign="top">RNA-seq</th>
<th align="center" valign="top">RT-qPCR</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top"><italic>lp1032</italic></td>
<td align="left" valign="top">30S ribosomal protein S10 (<italic>rpsJ</italic>)</td>
<td align="center" valign="top">1.61</td>
<td align="center" valign="top">1.89</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp1047</italic></td>
<td align="left" valign="top">50S ribosomal protein L5 (<italic>rplE</italic>)</td>
<td align="center" valign="top">1.51</td>
<td align="center" valign="top">1.77</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp1058</italic></td>
<td align="left" valign="top">Adenylate kinase (<italic>adk</italic>)</td>
<td align="center" valign="top">1.95</td>
<td align="center" valign="top">2.53</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp2900</italic></td>
<td align="left" valign="top">Hypothetical membrane protein</td>
<td align="center" valign="top">3.73</td>
<td align="center" valign="top">4.21</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp2710</italic></td>
<td align="left" valign="top">Xanthine permease</td>
<td align="center" valign="top">3.12</td>
<td align="center" valign="top">2.79</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp2830</italic></td>
<td align="left" valign="top">Aspartate ammonia-lyase (<italic>aspA</italic>)</td>
<td align="center" valign="top">2.71</td>
<td align="center" valign="top">2.54</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp2771</italic></td>
<td align="left" valign="top">Nicotinate phosphoribosyltransferase (<italic>pncB</italic>)</td>
<td align="center" valign="top">0.91</td>
<td align="center" valign="top">1.89</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp3556</italic></td>
<td align="left" valign="top"><sc>l</sc>-ribulokinase (<italic>araB</italic>)</td>
<td align="center" valign="top">3.47</td>
<td align="center" valign="top">3.66</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp3545</italic></td>
<td align="left" valign="top"><sc>d</sc>-arabitol-phosphate dehydrogenase (<italic>gutB</italic>)</td>
<td align="center" valign="top">1.44</td>
<td align="center" valign="top">1.52</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp0230</italic></td>
<td align="left" valign="top">PTS system % 2C mannitol-specific EIICB component</td>
<td align="center" valign="top">&#x2212;3.17</td>
<td align="center" valign="top">&#x2212;2.54</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp2302</italic></td>
<td align="left" valign="top">Nicotinamide-nucleotide amidase (<italic>cinA</italic>)</td>
<td align="center" valign="top">&#x2212;1.05</td>
<td align="center" valign="top">&#x2212;2.43</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp3555</italic></td>
<td align="left" valign="top">L-ribulose 5-phosphate 4-epimerase (<italic>araD</italic>)</td>
<td align="center" valign="top">&#x2212;2.44</td>
<td align="center" valign="top">&#x2212;2.31</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp2183</italic></td>
<td align="left" valign="top">ADP-ribose pyrophosphatase</td>
<td align="center" valign="top">&#x2212;1.40</td>
<td align="center" valign="top">&#x2212;2.50</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp2703</italic></td>
<td align="left" valign="top">Aspartate carbamoyltransferase (<italic>pyrB</italic>)</td>
<td align="center" valign="top">&#x2212;2.27</td>
<td align="center" valign="top">&#x2212;1.74</td>
</tr>
<tr>
<td align="left" valign="top"><italic>lp2251</italic></td>
<td align="left" valign="top">Ribokinase (<italic>rbsK2</italic>)</td>
<td align="center" valign="top">&#x2212;1.47</td>
<td align="center" valign="top">&#x2212;1.21</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec20">
<label>3.7</label>
<title>Characterization of <italic>cinA</italic> in NMN biosynthesis via CRISPR/Cas9</title>
<p>To further validate the influence of DEGs on NMN biosynthesis, we targeted <italic>cinA</italic>, encoding nicotinamide-nucleotide amidase, which was downregulated in the <italic>lp2514</italic>-overexpressing strain and implicated in NMN turnover (<xref ref-type="table" rid="tab4">Table 4</xref>). A <italic>cinA</italic> deletion mutant (WCFS1&#x0394;<italic>cinA</italic>) was constructed (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S3, S4</xref>) and assayed alongside wild-type WCFS1 for NMN production. As shown in <xref ref-type="fig" rid="fig10">Figure 10A</xref>, WCFS1&#x0394;<italic>cinA</italic> accumulated significantly greater amounts of NMN than did the parental strain 29%, which was consistent with the removal of the enzyme responsible for NMN degradation. <xref ref-type="bibr" rid="ref30">Zhang et al. (2024)</xref> similarly showed that deletion of the <italic>cinA</italic> in <italic>Bacillus subtilis</italic> enhanced NMN synthesis, consistent with our findings. RT-qPCR analysis (<xref ref-type="fig" rid="fig10">Figure 10B</xref>) revealed the absence of <italic>the cinA</italic> transcript in WCFS1&#x0394;<italic>cinA</italic> and the upregulation of key salvage pathway genes (e.g., <italic>aspA</italic>) and ribosomal components (<italic>rpsJ</italic>), mirroring the global enhancements in precursor flux and translational capacity identified by RNA-seq. These data substantiate a dual mechanism-enhanced NAM uptake via <italic>lp2514</italic> and prevention of NMN hydrolysis through <italic>cinA</italic> deletion-underscoring the value of combining transporter engineering with targeted gene knockouts to maximize NMN biosynthesis. Together, these findings highlight the robustness of the sequencing data and suggest that <italic>lp2514</italic> overexpression, in conjunction with NAM supplementation, modulates central carbon and nucleotide metabolism in <italic>L. plantarum</italic>. Such regulatory shifts are likely instrumental in enhancing NMN biosynthetic potential, laying a molecular foundation for further metabolic engineering aimed at boosting NAD<sup>+</sup> cofactor synthesis in <italic>Lactobacillus</italic>.</p>
<fig position="float" id="fig10">
<label>Figure 10</label>
<caption>
<p>Characterization of the effect of <italic>cinA</italic> on NMN biosynthesis via CRISPR/Cas9 in <italic>L. plantarum</italic> WCFS1. Intracellular NMN production of the WCFS1&#x0394;<italic>cinA</italic> mutant <bold>(A)</bold>. Analysis of the expression level of the WCFS1&#x0394;<italic>cinA</italic> mutant by RT-qPCR <bold>(B)</bold>. &#x002A;<italic>p</italic> &#x003C; 0.05 , &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic> &#x003C; 0.00001.</p>
</caption>
<graphic xlink:href="fmicb-16-1637666-g010.tif">
<alt-text content-type="machine-generated">Bar graphs A and B compare NMN production and relative expression levels between WCF51 and WCF51&#x0394;cinA conditions. Graph A shows higher NMN production in WCF51&#x0394;cinA. Graph B shows significantly lower relative expression in WCF51&#x0394;cinA, indicated by four asterisks.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="conclusions" id="sec21">
<label>4</label>
<title>Conclusion</title>
<p>In this study, <italic>lp2514</italic> was identified as a novel endogenous NAM transporter in <italic>L. plantarum</italic> through molecular docking and CRISPR/Cas9 validation. Overexpressing <italic>lp2514</italic>, particularly using multicopy expression strategy, significantly enhanced NAM uptake and activated NMN biosynthesis. Transcriptomic analysis revealed broad metabolic reprogramming, including upregulation of ribosomal and NAD<sup>+</sup> salvage pathway genes, supporting increased biosynthetic capacity. Furthermore, deletion of <italic>cinA</italic> further improved NMN yields and validated transcriptome-derived insights. These findings elucidate a new mechanism of NMN biosynthesis in LAB and establish <italic>L. plantarum</italic> as a promising food-grade chassis for sustainable, cost-effective NMN production. This work provides a foundation for engineering probiotics to develop functional foods enriched with bioactive NAD<sup>+</sup> precursors.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec22">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec sec-type="author-contributions" id="sec23">
<title>Author contributions</title>
<p>LK: Software, Writing &#x2013; review &#x0026; editing, Funding acquisition, Writing &#x2013; original draft, Validation. XL: Formal analysis, Data curation, Writing &#x2013; original draft. QH: Data curation, Writing &#x2013; original draft. QY: Investigation, Writing &#x2013; review &#x0026; editing. LA: Writing &#x2013; review &#x0026; editing. JQ: Writing &#x2013; original draft, Supervision, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec24">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was funded by National Natural Science Foundation of China (Grant no. 32302050) and Natural Science Foundation of Shandong Province (Grant no. ZR2022QC004).</p>
</sec>
<sec sec-type="COI-statement" id="sec25">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec26">
<title>Generative AI statement</title>
<p>The authors declare that no Gen AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="sec27">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec28">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2025.1637666/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2025.1637666/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname> <given-names>T.</given-names></name> <name><surname>Weng</surname> <given-names>P.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Cui</surname> <given-names>J.</given-names></name> <name><surname>Tao</surname> <given-names>Y.</given-names></name> <name><surname>Huang</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>Systematic engineering for high-level production of &#x03B2;-nicotinamide mononucleotide from NAM and ribose</article-title>. <source>Food Biosci.</source> <volume>63</volume>:<fpage>105725</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.fbio.2024.105725</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname> <given-names>T.</given-names></name> <name><surname>Wu</surname> <given-names>T.</given-names></name> <name><surname>Yang</surname> <given-names>L.</given-names></name> <name><surname>Xu</surname> <given-names>Y.</given-names></name> <name><surname>Mu</surname> <given-names>X.</given-names></name></person-group> (<year>2023</year>). <article-title>Comprehensive transformation of <italic>Escherichia coli</italic> for nicotinamide mononucleotide production</article-title>. <source>Catalysts</source> <volume>13</volume>:<fpage>815</fpage>. doi: <pub-id pub-id-type="doi">10.3390/catal13050815</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>F.</given-names></name> <name><surname>Li</surname> <given-names>K. X.</given-names></name> <name><surname>Wu</surname> <given-names>S. S.</given-names></name> <name><surname>Liu</surname> <given-names>H. Y.</given-names></name> <name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Shen</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Biosynthesis of nicotinamide mononucleotide: synthesis method, enzyme, and biocatalytic system</article-title>. <source>J. Agric. Food Chem.</source> <volume>72</volume>, <fpage>3302</fpage>&#x2013;<lpage>3313</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.jafc.3c09217</pub-id>, PMID: <pub-id pub-id-type="pmid">38330904</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>J.</given-names></name> <name><surname>Zuo</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>G.</given-names></name> <name><surname>Li</surname> <given-names>D.</given-names></name> <name><surname>Gao</surname> <given-names>J.</given-names></name> <name><surname>Xiao</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Development of a Pichia pastoris cell factory for efficient production of germacrene a: a precursor of beta-elemene</article-title>. <source>Bioresour. Bioprocess.</source> <volume>10</volume>:<fpage>38</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40643-023-00657-0</pub-id>, PMID: <pub-id pub-id-type="pmid">38647946</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>Z.</given-names></name> <name><surname>Yang</surname> <given-names>X.</given-names></name> <name><surname>Tian</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Liu</surname> <given-names>M.</given-names></name></person-group> (<year>2022</year>). <article-title>Yeast cell surface engineering of a nicotinamide riboside kinase for the production of beta-nicotinamide mononucleotide via whole-cell catalysis</article-title>. <source>ACS Synth. Biol.</source> <volume>11</volume>, <fpage>3451</fpage>&#x2013;<lpage>3459</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acssynbio.2c00350</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>Z.</given-names></name> <name><surname>Li</surname> <given-names>N.</given-names></name> <name><surname>Yu</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>W.</given-names></name> <name><surname>Zhang</surname> <given-names>T.</given-names></name> <name><surname>Zhou</surname> <given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Systematic engineering of <italic>Escherichia coli</italic> for efficient production of nicotinamide mononucleotide from nicotinamide</article-title>. <source>ACS Synth. Biol.</source> <volume>11</volume>, <fpage>2979</fpage>&#x2013;<lpage>2988</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acssynbio.2c00100</pub-id>, PMID: <pub-id pub-id-type="pmid">35977419</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>H.</given-names></name> <name><surname>Song</surname> <given-names>X.</given-names></name> <name><surname>Yang</surname> <given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Development of a RecE/T-assisted CRISPR-Cas9 toolbox for Lactobacillus</article-title>. <source>Biotechnol. J.</source> <volume>14</volume>:<fpage>e1800690</fpage>. doi: <pub-id pub-id-type="doi">10.1002/biot.201800690</pub-id>, PMID: <pub-id pub-id-type="pmid">30927506</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>Z.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>N.</given-names></name> <name><surname>Song</surname> <given-names>F.</given-names></name> <name><surname>Zhou</surname> <given-names>J.</given-names></name></person-group> (<year>2023</year>). <article-title>Systematic engineering of <italic>Escherichia coli</italic> for efficient production of nicotinamide riboside from nicotinamide and 3-cyanopyridine</article-title>. <source>Bioresour. Technol.</source> <volume>377</volume>:<fpage>128953</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biortech.2023.128953</pub-id>, PMID: <pub-id pub-id-type="pmid">36963699</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeanguenin</surname> <given-names>L.</given-names></name> <name><surname>Lara-Nunez</surname> <given-names>A.</given-names></name> <name><surname>Rodionov</surname> <given-names>D. A.</given-names></name> <name><surname>Osterman</surname> <given-names>A. L.</given-names></name> <name><surname>Komarova</surname> <given-names>N. Y.</given-names></name> <name><surname>Rentsch</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Comparative genomics and functional analysis of the NiaP family uncover nicotinate transporters from bacteria, plants, and mammals</article-title>. <source>Funct. Integr. Genomics</source> <volume>12</volume>, <fpage>25</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10142-011-0255-y</pub-id>, PMID: <pub-id pub-id-type="pmid">21953179</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kleerebezem</surname> <given-names>M.</given-names></name> <name><surname>Boekhorst</surname> <given-names>J.</given-names></name> <name><surname>Van Kranenburg</surname> <given-names>R.</given-names></name> <name><surname>Molenaar</surname> <given-names>D.</given-names></name> <name><surname>Kuipers</surname> <given-names>O. P.</given-names></name> <name><surname>Leer</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>Complete genome sequence of <italic>Lactobacillus plantarum</italic> WCFS1</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>100</volume>, <fpage>1990</fpage>&#x2013;<lpage>1995</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0337704100</pub-id>, PMID: <pub-id pub-id-type="pmid">12566566</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname> <given-names>L. H.</given-names></name> <name><surname>Li</surname> <given-names>X. Y.</given-names></name> <name><surname>Liu</surname> <given-names>T. Y.</given-names></name> <name><surname>Yao</surname> <given-names>Q. S.</given-names></name> <name><surname>Qin</surname> <given-names>J. Y.</given-names></name></person-group> (<year>2024</year>). <article-title>Harnessing lactic acid bacteria for nicotinamide mononucleotide biosynthesis: a review of strategies and future directions</article-title>. <source>Front. Microbiol.</source> <volume>15</volume>:<fpage>1492179</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2024.1492179</pub-id>, PMID: <pub-id pub-id-type="pmid">39735184</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname> <given-names>L. H.</given-names></name> <name><surname>Liu</surname> <given-names>T. Y.</given-names></name> <name><surname>Yao</surname> <given-names>Q. S.</given-names></name> <name><surname>Zhang</surname> <given-names>X. H.</given-names></name> <name><surname>Xu</surname> <given-names>W. N.</given-names></name> <name><surname>Qin</surname> <given-names>J. Y.</given-names></name></person-group> (<year>2023</year>). <article-title>Enhancing the biosynthesis of nicotinamide mononucleotide in <italic>Lactococcus lactis</italic> by heterologous expression of FtnadE</article-title>. <source>J. Sci. Food Agric.</source> <volume>103</volume>, <fpage>450</fpage>&#x2013;<lpage>456</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jsfa.12253</pub-id>, PMID: <pub-id pub-id-type="pmid">36205212</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname> <given-names>L.</given-names></name> <name><surname>Xiong</surname> <given-names>Z.</given-names></name> <name><surname>Song</surname> <given-names>X.</given-names></name> <name><surname>Xia</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Enhanced antioxidant activity in <italic>Streptococcus thermophilus</italic> by high-level expression of superoxide dismutase</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>:<fpage>579804</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.579804</pub-id>, PMID: <pub-id pub-id-type="pmid">33281773</pub-id></citation></ref>
<ref id="ref9001"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuerec</surname> <given-names>A. H.</given-names></name> <name><surname>Wang</surname> <given-names>W.</given-names></name> <name><surname>Yi</surname> <given-names>L.</given-names></name> <name><surname>Tao</surname> <given-names>R.</given-names></name> <name><surname>Lin</surname> <given-names>Z.</given-names></name> <name><surname>Vaidya</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Towards personalized nicotinamide mononucleotide (NMN) supplementation: Nicotinamide adenine dinucleotide (NAD) concentration</article-title>. <source>Mechanisms of Ageing and Development</source>, <volume>218</volume>:<fpage>111917</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mad.2024.111917</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Yasawong</surname> <given-names>M.</given-names></name> <name><surname>Yu</surname> <given-names>B.</given-names></name></person-group> (<year>2021</year>). <article-title>Metabolic engineering of <italic>Escherichia coli</italic> for biosynthesis of beta-nicotinamide mononucleotide from nicotinamide</article-title>. <source>Microb. Biotechnol.</source> 14, 2581&#x2013;2591. doi: <pub-id pub-id-type="doi">10.1111/1751-7915.13901</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Z.</given-names></name> <name><surname>Zhang</surname> <given-names>Z.</given-names></name> <name><surname>Qiu</surname> <given-names>L.</given-names></name> <name><surname>Zhang</surname> <given-names>F.</given-names></name> <name><surname>Xu</surname> <given-names>X.</given-names></name> <name><surname>Wei</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Characterization and bioactivities of the exopolysaccharide from a probiotic strain of <italic>Lactobacillus plantarum</italic> WLPL04</article-title>. <source>J. Dairy Sci.</source> <volume>100</volume>, <fpage>6895</fpage>&#x2013;<lpage>6905</lpage>. doi: <pub-id pub-id-type="doi">10.3168/jds.2016-11944</pub-id>, PMID: <pub-id pub-id-type="pmid">28711240</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>S. Q.</given-names></name> <name><surname>Zhao</surname> <given-names>J. T.</given-names></name> <name><surname>Zheng</surname> <given-names>Y. Y.</given-names></name> <name><surname>Chen</surname> <given-names>T.</given-names></name> <name><surname>Wang</surname> <given-names>Z. W.</given-names></name></person-group> (<year>2023</year>). <article-title>Biosynthesis of nicotinamide mononucleotide: current metabolic engineering strategies, challenges, and prospects</article-title>. <source>Fermentation</source> <volume>9</volume>:<fpage>594</fpage>. doi: <pub-id pub-id-type="doi">10.3390/fermentation9070594</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maharjan</surname> <given-names>A.</given-names></name> <name><surname>Singhvi</surname> <given-names>M.</given-names></name> <name><surname>Kafle</surname> <given-names>S. R.</given-names></name> <name><surname>Kim</surname> <given-names>B. S.</given-names></name></person-group> (<year>2023</year>). <article-title>Enhanced production of nicotinamide mononucleotide by high cell density culture of engineered <italic>Escherichia coli</italic></article-title>. <source>Process Biochem.</source> <volume>131</volume>, <fpage>264</fpage>&#x2013;<lpage>271</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.procbio.2023.07.002</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maharjan</surname> <given-names>A.</given-names></name> <name><surname>Singhvi</surname> <given-names>M.</given-names></name> <name><surname>Kim</surname> <given-names>B. S.</given-names></name></person-group> (<year>2021</year>). <article-title>Biosynthesis of a therapeutically important nicotinamide mononucleotide through a phosphoribosyl pyrophosphate synthetase 1 and 2 engineered strain of <italic>Escherichia coli</italic></article-title>. <source>ACS Synth. Biol.</source> <volume>10</volume>, <fpage>3055</fpage>&#x2013;<lpage>3065</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acssynbio.1c00333</pub-id>, PMID: <pub-id pub-id-type="pmid">34747173</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marinescu</surname> <given-names>G. C.</given-names></name> <name><surname>Popescu</surname> <given-names>R. G.</given-names></name> <name><surname>Stoian</surname> <given-names>G.</given-names></name> <name><surname>Dinischiotu</surname> <given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>beta-nicotinamide mononucleotide (NMN) production in <italic>Escherichia coli</italic></article-title>. <source>Sci. Rep.</source> <volume>8</volume>:<fpage>12278</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-018-30792-0</pub-id>, PMID: <pub-id pub-id-type="pmid">30115969</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nadeeshani</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>J. Y.</given-names></name> <name><surname>Ying</surname> <given-names>T. L.</given-names></name> <name><surname>Zhang</surname> <given-names>B. H.</given-names></name> <name><surname>Lu</surname> <given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Nicotinamide mononucleotide (NMN) as an anti-aging health product-promises and safety concerns</article-title>. <source>J. Adv. Res.</source> <volume>37</volume>, <fpage>267</fpage>&#x2013;<lpage>278</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jare.2021.08.003</pub-id>, PMID: <pub-id pub-id-type="pmid">35499054</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oleksy</surname> <given-names>M.</given-names></name> <name><surname>Klewicka</surname> <given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Exopolysaccharides produced by Lactobacillus sp.: biosynthesis and applications</article-title>. <source>Crit. Rev. Food Sci. Nutr.</source> <volume>58</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1080/10408398.2016.1187112</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poddar</surname> <given-names>S. K.</given-names></name> <name><surname>Sifat</surname> <given-names>A. E.</given-names></name> <name><surname>Haque</surname> <given-names>S.</given-names></name> <name><surname>Nahid</surname> <given-names>N. A.</given-names></name> <name><surname>Chowdhury</surname> <given-names>S.</given-names></name> <name><surname>Mehedi</surname> <given-names>I.</given-names></name></person-group> (<year>2019</year>). <article-title>Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule</article-title>. <source>Biomolecules</source> <volume>9</volume>:<fpage>34</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biom9010034</pub-id>, PMID: <pub-id pub-id-type="pmid">30669679</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shoji</surname> <given-names>S.</given-names></name> <name><surname>Yamaji</surname> <given-names>T.</given-names></name> <name><surname>Makino</surname> <given-names>H.</given-names></name> <name><surname>Ishii</surname> <given-names>J.</given-names></name> <name><surname>Kondo</surname> <given-names>A.</given-names></name></person-group> (<year>2021</year>). <article-title>Metabolic design for selective production of nicotinamide mononucleotide from glucose and nicotinamide</article-title>. <source>Metab. Eng.</source> <volume>65</volume>, <fpage>167</fpage>&#x2013;<lpage>177</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ymben.2020.11.008</pub-id>, PMID: <pub-id pub-id-type="pmid">33220420</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>C.</given-names></name> <name><surname>Cheng</surname> <given-names>L.</given-names></name> <name><surname>Gong</surname> <given-names>J. S.</given-names></name> <name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Xu</surname> <given-names>Z. H.</given-names></name> <name><surname>Shi</surname> <given-names>J. S.</given-names></name></person-group> (<year>2024</year>). <article-title>Systematic engineering for efficient production of nicotinamide mononucleotide from d-xylose and nicotinamide in <italic>Escherichia coli</italic></article-title>. <source>Food Biosci.</source> <volume>59</volume>:<fpage>103859</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.fbio.2024.103859</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sugiyama</surname> <given-names>K.</given-names></name> <name><surname>Iijima</surname> <given-names>K.</given-names></name> <name><surname>Yoshino</surname> <given-names>M.</given-names></name> <name><surname>Dohra</surname> <given-names>H.</given-names></name> <name><surname>Tokimoto</surname> <given-names>Y.</given-names></name> <name><surname>Nishikawa</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Nicotinamide mononucleotide production by fructophilic lactic acid bacteria</article-title>. <source>Sci. Rep.</source> <volume>11</volume>:<fpage>7662</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-021-87361-1</pub-id>, PMID: <pub-id pub-id-type="pmid">33828213</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>L.</given-names></name> <name><surname>Li</surname> <given-names>N.</given-names></name> <name><surname>Yu</surname> <given-names>S.</given-names></name> <name><surname>Zhou</surname> <given-names>J.</given-names></name></person-group> (<year>2023</year>). <article-title>Enhancing caffeic acid production in <italic>Escherichia coli</italic> by engineering the biosynthesis pathway and transporter</article-title>. <source>Bioresour. Technol.</source> <volume>368</volume>:<fpage>128320</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biortech.2022.128320</pub-id>, PMID: <pub-id pub-id-type="pmid">36379296</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname> <given-names>B.</given-names></name> <name><surname>Yang</surname> <given-names>T.</given-names></name> <name><surname>Zhang</surname> <given-names>Z.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name> <name><surname>Yu</surname> <given-names>H.</given-names></name> <name><surname>Wang</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>Metabolic reprogramming and machine learning-guided cofactor engineering to boost nicotinamide mononucleotide production in <italic>Escherichia coli</italic></article-title>. <source>Bioresour. Technol.</source> <volume>426</volume>:<fpage>132350</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biortech.2025.132350</pub-id>, PMID: <pub-id pub-id-type="pmid">40054751</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>L. Y.</given-names></name> <name><surname>Mu</surname> <given-names>X. Q.</given-names></name> <name><surname>Nie</surname> <given-names>Y.</given-names></name> <name><surname>Xu</surname> <given-names>Y.</given-names></name></person-group> (<year>2021</year>). <article-title>Improving the production of NAD(+) via multi-strategy metabolic engineering in <italic>Escherichia coli</italic></article-title>. <source>Metab. Eng.</source> <volume>64</volume>, <fpage>122</fpage>&#x2013;<lpage>133</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ymben.2021.01.012</pub-id>, PMID: <pub-id pub-id-type="pmid">33577950</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshino</surname> <given-names>J.</given-names></name> <name><surname>Baur</surname> <given-names>J. A.</given-names></name> <name><surname>Imai</surname> <given-names>S. I.</given-names></name></person-group> (<year>2018</year>). <article-title>NAD(+) intermediates: the biology and therapeutic potential of NMN and NR</article-title>. <source>Cell Metab.</source> <volume>27</volume>, <fpage>513</fpage>&#x2013;<lpage>528</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2017.11.002</pub-id>, PMID: <pub-id pub-id-type="pmid">29249689</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>S.</given-names></name> <name><surname>Liu</surname> <given-names>M.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Yuan</surname> <given-names>D.</given-names></name> <name><surname>Sun</surname> <given-names>S.</given-names></name></person-group> (<year>2024</year>). <article-title>A native phosphoribosyltransferase, PncB, is the key NMN synthase in <italic>Bacillus subtilis</italic></article-title>. <source>Process Biochem.</source> <volume>139</volume>, <fpage>137</fpage>&#x2013;<lpage>145</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.procbio.2024.02.004</pub-id></citation></ref>
</ref-list>
</back>
</article>